🟢 Neumora Therapeutics is trading 8.1% up in after-hours trading with no specific catalyst identified

Neumora Therapeutics is trading at $0.41, up 8.09% after hours, with no new company announcement identified to explain the rise.

• The price is versus the October 23 regular-session close of $0.38.
• Recent pressure followed disappointing Phase 3 navacaprant results, but that earlier news does not establish the cause of this move; available market context is mixed.
• No verified after-hours volume or specific catalyst was available.